These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31099033)

  • 1. Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.
    Toyoda K; Tsukasaki K; Machida R; Kadota T; Fukushima T; Ishitsuka K; Maruyama D; Nagai H
    Br J Haematol; 2019 Aug; 186(3):440-447. PubMed ID: 31099033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
    Tsukasaki K; Utsunomiya A; Fukuda H; Shibata T; Fukushima T; Takatsuka Y; Ikeda S; Masuda M; Nagoshi H; Ueda R; Tamura K; Sano M; Momita S; Yamaguchi K; Kawano F; Hanada S; Tobinai K; Shimoyama M; Hotta T; Tomonaga M;
    J Clin Oncol; 2007 Dec; 25(34):5458-64. PubMed ID: 17968021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis.
    Fuji S; Yamaguchi T; Inoue Y; Utsunomiya A; Moriuchi Y; Owatari S; Miyagi T; Sawayama Y; Otsuka E; Yoshida SI; Fukuda T
    Bone Marrow Transplant; 2019 Sep; 54(9):1399-1405. PubMed ID: 30664725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
    Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
    Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
    Yamada Y; Tomonaga M; Fukuda H; Hanada S; Utsunomiya A; Tara M; Sano M; Ikeda S; Takatsuki K; Kozuru M; Araki K; Kawano F; Niimi M; Tobinai K; Hotta T; Shimoyama M
    Br J Haematol; 2001 May; 113(2):375-82. PubMed ID: 11380402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.
    Makiyama J; Imaizumi Y; Tsushima H; Taniguchi H; Moriwaki Y; Sawayama Y; Imanishi D; Taguchi J; Hata T; Tsukasaki K; Miyazaki Y
    Int J Hematol; 2014 Nov; 100(5):464-72. PubMed ID: 25209605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
    Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
    Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort.
    Nishi Y; Fukushima T; Nomura S; Tomoyose T; Nakachi S; Morichika K; Tedokon I; Tamaki K; Shimabukuro N; Taira N; Miyagi T; Karimata K; Ohama M; Yamanoha A; Tamaki K; Hayashi M; Arakaki H; Uchihara JN; Ohshiro K; Asakura Y; Kuba-Miyara M; Karube K; Masuzaki H
    Int J Hematol; 2016 Oct; 104(4):468-75. PubMed ID: 27329124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.
    Alduaij A; Butera JN; Treaba D; Castillo J
    Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area.
    Nakamura D; Yoshimitsu M; Tabuchi T; Arima N; Hayashida M; Inoue H; Matsushita K; Matsumoto T; Arima N; Ishitsuka K
    Int J Hematol; 2020 Feb; 111(2):234-240. PubMed ID: 31721034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
    Ishida T; Jo T; Takemoto S; Suzushima H; Uozumi K; Yamamoto K; Uike N; Saburi Y; Nosaka K; Utsunomiya A; Tobinai K; Fujiwara H; Ishitsuka K; Yoshida S; Taira N; Moriuchi Y; Imada K; Miyamoto T; Akinaga S; Tomonaga M; Ueda R
    Br J Haematol; 2015 Jun; 169(5):672-82. PubMed ID: 25733162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T-cell leukemia-lymphoma.
    Tsukasaki K
    Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States.
    Roe C; Komrokji R; Zhang L; Price S; Sokol L
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S191-4. PubMed ID: 27521318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma.
    Jo T; Matsuzaka K; Shioya H; Tominaga H; Sakai T; Kaneko Y; Hayashi S; Matsuo M; Taguchi J; Abe K; Shigematsu K; Kubota-Koketsu R
    Anticancer Res; 2020 Sep; 40(9):5237-5243. PubMed ID: 32878812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
    Itoh K; Ohtsu T; Fukuda H; Sasaki Y; Ogura M; Morishima Y; Chou T; Aikawa K; Uike N; Mizorogi F; Ohno T; Ikeda S; Sai T; Taniwaki M; Kawano F; Niimi M; Hotta T; Shimoyama M; Tobinai K;
    Ann Oncol; 2002 Sep; 13(9):1347-55. PubMed ID: 12196359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disease-oriented treatment of T/NK-cell lymphomas].
    Tobinai K
    Rinsho Ketsueki; 2016 Aug; 57(8):1044-51. PubMed ID: 27599422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult T-cell leukemia/lymphoma treatment in Bahia, Brazil.
    Oliveira PD; Gomes Í; Souza VH; Pires EC; Arruda GB; Bittencourt A
    Rev Bras Hematol Hemoter; 2017; 39(1):13-19. PubMed ID: 28270340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL).
    Kawano N; Shimonodan H; Nagahiro Y; Yoshida S; Kuriyama T; Takigawa K; Tochigi T; Nakaike T; Makino S; Yamashita K; Marutsuka K; Ochiai H; Mori Y; Shimoda K; Ohshima K; Mashiba K; Kikuchi I
    J Clin Exp Hematop; 2023; 63(2):73-82. PubMed ID: 37380472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.